businesspress24.com - Innoviva to Present at the Cowen & Company 36th Annual Health Care Conference 2016
 

Innoviva to Present at the Cowen & Company 36th Annual Health Care Conference 2016

ID: 1418875

(firmenpresse) - SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 03/01/16 -- Innoviva, Inc. (NASDAQ: INVA) announced today that Michael W. Aguiar, Innoviva''s President and Chief Executive Officer, is scheduled to present at the Cowen & Company 36th Annual Health Care Conference on Tuesday, March 8, 2016 at 10:40 a.m. EST. The conference will be held from March 7-9, 2016 in Boston, MA.

The presentation will be webcast live and can be accessed from Innoviva''s website at . Listeners are encouraged to visit the site at least 15 minutes prior to the scheduled presentation to register, download and install any necessary audio software.

Innoviva, formerly known as Theravance, Inc., is focused on bringing compelling new medicines to patients in areas of unmet need by leveraging its significant expertise in the development, commercialization and financial management of bio-pharmaceuticals. Innoviva''s portfolio is anchored by the respiratory assets partnered with Glaxo Group Limited (GSK), including RELVAR®/BREO® ELLIPTA® and ANORO® ELLIPTA®, which were jointly developed by Innoviva and GSK. Under the agreement with GSK, Innoviva is eligible to receive associated royalty revenues from RELVAR®/BREO® ELLIPTA®, ANORO® ELLIPTA® and, if approved and commercialized, VI monotherapy, as well. In addition, Innoviva retains a 15 percent economic interest in future payments made by GSK for earlier-stage programs partnered with Theravance BioPharma, Inc. For more information, please visit Innoviva''s website at .

ANORO®, RELVAR®, BREO® and ELLIPTA® are trademarks of the GlaxoSmithKline group of companies.

(INVA-F)



Eric d''Esparbes
Senior Vice President and Chief Financial Officer
650-238-9640



Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:



Leseranfragen:



PresseKontakt / Agentur:



drucken  als PDF  an Freund senden  Acasti Announces Management Appointment and Changes to the Board of Directors
Theravance Biopharma to Report Fourth Quarter and Full Year 2015 Financial Results on March 9, 2016
Bereitgestellt von Benutzer: Marketwired
Datum: 01.03.2016 - 15:05 Uhr
Sprache: Deutsch
News-ID 1418875
Anzahl Zeichen: 2533

contact information:
Contact person:
Town:

SOUTH SAN FRANCISCO, CA


Phone:

Kategorie:

Drugs


Typ of Press Release:
type of sending:
Date of sending:
Anmerkungen:


Diese Pressemitteilung wurde bisher 159 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Innoviva to Present at the Cowen & Company 36th Annual Health Care Conference 2016
"
steht unter der journalistisch-redaktionellen Verantwortung von

Innoviva, Inc. (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Innoviva, Inc.



 

Who is online

All members: 10 563
Register today: 2
Register yesterday: 2
Members online: 0
Guests online: 87


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.